Polaryx Therapeutics PLYX Income Statement (2024-2026)

NASDAQ PLYX
$2.02 -0.05 (-2.42%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Polaryx Therapeutics Quarterly Income Statement

Periods 6 quarters
Latest Jun 2026

Polaryx Therapeutics reported net income of -$1.38M for the quarter ended Jun 2026. This income statement covers 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2024 Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Operating items
Research & DevelopmentR&D 4.72M0.48M0.68M0.72M
Share-based Compensation (IS)Stock Comp. 0.11M
Selling, General & AdministrativeSG&A 0.34M0.41M1.28M0.66M
Operating ExpensesOpex 5.05M0.88M1.96M1.38M
Operating IncomeOp. Inc -5.05M-0.88M-1.96M-1.38M
EBIT -5.05M-0.88M-1.96M-1.38M
Net income details
EBT -5.05M-0.88M-1.96M-1.38M
Profit After TaxPAT -5.05M-0.88M-1.96M-1.38M
Income from Continuing OperationsIncome (Continuing) -5.05M-0.88M-1.96M-1.38M
Consolidated Net IncomeConsol Net Inc. -5.05M-0.88M-1.96M-1.38M
Income towards Parent CompanyParent Net Inc -5.10M-1.01M-2.54M-1.40M
Net Income towards Common StockholdersNet Income -5.05M-1.01M-2.54M-1.38M
Additional items
EPS (Basic) -0.11-0.02-0.05-0.03
EPS (Diluted) -0.11-0.02-0.05-0.03
Shares Outstanding 34.20M44.34M44.67M45.42M47.22M48.28M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 34.20M44.34M44.67M45.42M47.22M48.28M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 34.20M45.07M45.07M47.34M47.34M49.85M

Polaryx Therapeutics Income Statement API

Pull Polaryx Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PLYX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY